Muscle Dysmorphia in Elite‐Level Power Lifters and Bodybuilders: A Test of Differences Within a Conceptual Model

Muscle Dysmorphia in Elite‐Level Power Lifters and Bodybuilders: A Test of Differences Within a Conceptual Model
复制标题

精英级力量举重运动员和健美运动员的肌肉畸形:概念模型差异的测试

DOI:
--
复制
发表时间:
2002
影响因子:
3.2
通讯作者:
A. Cornelius
A. Cornelius
中科院分区:
医学2区
文献类型:
--
作者:
C. Lantz;D. Rhea;A. Cornelius

文献摘要

被引文献

相似文献

本研究的目的是确定是否肌肉畸形(MD)的相关特征是不同的精英级竞技健美运动员和力量举重运动员。精英级竞技健美运动员(n = 100)和力量举重运动员(n = 68)在比赛时或比赛前完成了肌肉功能障碍清单(MDI)。A 2 × 6(组× MDI分量表)多变量方差分析表明,健美运动员更有可能报告身体大小对称性问题(F(1,167)= 10.31,p < 0.001),体质保护(F(1,167)= 10.27,p < 0.001)、饮食行为(F(1,167)= 28.38,p < 0.001)和药物使用(F(1,167)= 19.64,p < 0.001)。这些结果表明,精英级别的健美运动员比精英级别的力量举重运动员更有可能参与与MD相关的特征。
The purpose of this study was to determine if associated characteristics of muscle dysmorphia (MD) were different between elite-level competitive bodybuilders and power lifters. Elite-level competitive bodybuilders (n = 100) and power lifters (n = 68) completed the muscle dysmorphia inventory (MDI) at the time of or immediately before competition. A 2 × 6 (group × MDI subscales) multivariate analysis of variance indicated that bodybuilders were significantly more likely to report body size-symmetry concerns (F(1, 167) = 10.31, p < 0.001), physique protection (F(1, 167) = 10.27, p < 0.001), dietary behavior (F(1, 167) = 28.38, p < 0.001), and pharmacological use (F(1, 167) = 19.64, p < 0.001) than were power lifters. These results suggest that elite-level bodybuilders are significantly more likely to engage in characteristics associated with MD than are elite-level power lifters.